EUVIMEDEUVIMED entdecken
Crossref

Expression of Anoikis-Related Genes and Potential Biomarkers in Colon Cancer Based on RNA-seq and scRNA-seq

Ti Guo, Yadong Wang

Applied Biochemistry and Biotechnology · 2024

DOI: 10.1007/s12010-024-04957-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Biochemistry and Biotechnology, 2024. Verfasst von Ti Guo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Cancer Hospital,Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430079, Hubei, China. Hauptthemen laut MEDLINE: Colonic Neoplasms, Biomarkers, Tumor, Anoikis. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colon cancer (CC) is a malignant tumor in the colon. Despite some progress in the early detection and treatment of CC in recent years, some patients still experience recurrence and metastasis. Therefore, it is urgent to better predict the prognosis of CC patients and identify new biomarkers. Recent studies have shown that anoikis-related genes (ARGs) play a significant role in the progression of many tumors. Hence, it is essential to confirm the role of ARGs in the development and treatment of CC by integrating scRNA-seq and transcriptome data. This study integrated transcriptome and single-cell sequencing (scRNA-seq) data from CC samples to evaluate patient stratification, prognosis, and ARG expression in different cell types. Specifically, differential expression of ARGs was identified through consensus clustering to classify CC subtypes. Subsequently, a CC risk model composed of CDKN2A, NOX4, INHBB, CRYAB, TWIST1, CD36, SERPINE1, and MMP3 was constructed using prognosis-related ARGs. Finally, using scRNA-seq data of CC, the expression landscape of prognostic genes in different cell types and the relationship between important immune cells and other cells were explored. Through the above analysis, two CC subtypes were identified, showing significant differences in prognosis and clinical factors. Subsequently, a risk model comprising aforementioned genes successfully categorized all CC samples into two risk groups, which also exhibited significant differences in prognosis, clinical factors, involved pathways, immune landscape, and drug sensitivity. Multiple pathways (cell adhesion molecules (CAMs), and extracellular matrix (ECM) receptor interaction) and immune cells/immune functions (B cell naive, dendritic cell activate, plasma cells, and T cells CD4 memory activated) related to CC were identified. Furthermore, it was found that prognostic genes were highly expressed in various immune cells, and B cells exhibited more and stronger interaction pathways with other cells. The results of this study may provide references for personalized treatment and potential biomarker identification in CC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colonic NeoplasmsBiomarkers, TumorAnoikisHumansGene Expression Regulation, NeoplasticPrognosisSingle-Cell AnalysisRNA-SeqTranscriptomeSingle-Cell Gene Expression Analysis

Stichwörter der Autor:innen

AnoikisColon cancerConsensus clusteringRNA-seqRisk modelscRNA-seq

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Hubei Cancer Hospital,Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430079, Hubei, China.
  • Wuhan Hospital of Traditional Chinese Medicine, Wuhan, 430014, Hubei, China. 329458963@qq.com.

Zitieren

APA

Guo, T., & Wang, Y. (2024). Expression of Anoikis-Related Genes and Potential Biomarkers in Colon Cancer Based on RNA-seq and scRNA-seq. Applied Biochemistry and Biotechnology. https://doi.org/10.1007/s12010-024-04957-9

Vancouver

Guo T, Wang Y. Expression of Anoikis-Related Genes and Potential Biomarkers in Colon Cancer Based on RNA-seq and scRNA-seq. Applied Biochemistry and Biotechnology. 2024. doi:10.1007/s12010-024-04957-9

BibTeX
@article{Guo2024,
  author = {Guo, Ti and Wang, Yadong},
  title = {Expression of Anoikis-Related Genes and Potential Biomarkers in Colon Cancer Based on RNA-seq and scRNA-seq},
  journal = {Applied Biochemistry and Biotechnology},
  year = {2024},
  doi = {10.1007/s12010-024-04957-9}
}
Kostenlos starten →